United States · FDA National Drug Code directory
BUPIVACAINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-506_570a9a90-b2e1-2db5-e063-6294a90a1bcb
- Product NDC
- 72603-506
- Form
- INJECTION, SOLUTION
- Composition / generic term
- BUPIVACAINE HYDROCHLORIDE
- Labeler
- NorthStar RxLLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241001
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-506-10) / 10 mL in 1 VIAL, SINGLE-DOSE (72603-506-01) · 72603-506-10
- 25 VIAL, SINGLE-DOSE in 1 CARTON (72603-506-25) / 10 mL in 1 VIAL, SINGLE-DOSE (72603-506-01) · 72603-506-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →